[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Stemgent Inc - Strategic SWOT Analysis Review

May 2018 | 22 pages | ID: S33988DA7DEEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Stemgent Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Stemgent Inc (Stemgent), a part of the ReproCELL Group is a biotechnology company that focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The company’s product portfolio comprises antibodies, cell lines, cytokines / proteins, differentiation, matrices, media, reprogramming systems, small molecules and transfection. It also offers iPS cell services and training courses for research scholars of various research laboratories. These training courses cover all essential protocols for lentiviral and mRNA reprogramming and human induced pluripotent (iPS) cell culture techniques in a hands-on laboratory environment. The company operates research sites in Cambridge, Massachusetts and San Diego, California. Stemgent is headquartered in Cambridge, Massachusetts, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Stemgent Inc - Key Facts
Stemgent Inc - Key Employees
Stemgent Inc - Major Products and Services
Stemgent Inc - History
Stemgent Inc - Company Statement
Stemgent Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Stemgent Inc - Business Description
Stemgent Inc - SWOT Analysis
SWOT Analysis - Overview
Stemgent Inc - Strengths
Stemgent Inc - Weaknesses
Stemgent Inc - Opportunities
Stemgent Inc - Threats
Stemgent Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Stemgent Inc, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Stemgent Inc, Key Facts
Stemgent Inc, Key Employees
Stemgent Inc, Major Products and Services
Stemgent Inc, History
Stemgent Inc, Other Locations
Stemgent Inc, Key Competitors
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Stemgent Inc, Recent Deals Summary

LIST OF FIGURES

Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Stemgent Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Astellas Institute for Regenerative Medicine
iPierian Inc
Microbot Medical Inc
Neuralstem Inc
ViaCyte Inc


More Publications